249 results on '"Meduri, Gianfranco"'
Search Results
2. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
3. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS
4. Diagnostic workup for ARDS patients
5. Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness
6. Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS
7. Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us
8. Predicting individualized treatment effects of corticosteroids in community-acquired-pneumonia: a data-driven analysis of randomized controlled trials
9. 669
10. Corticosteroids in pediatric ARDS: all cards on the table
11. General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections
12. Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
13. Patient-Level Meta-Analysis of Low-Dose Hydrocortisone in Adults with Septic Shock
14. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017
15. Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)
16. Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS
17. Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
18. Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
19. Understanding ARDS-associated fibroproliferation
20. Correction to: Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017
21. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
22. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment
23. POINT: Should Corticosteroids Be Routine Treatment in Early ARDS? Yes
24. Rebuttal From Drs Meduri and Rochwerg
25. Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations
26. Exaggerated Systemic Inflammation and Development of Health-care Associated Infections
27. Reply to Ñamendys-Silva and Salluh
28. Diffuse alveolar damage in nonresolving ARDS provides support for prolonged glucocorticoid treatment
29. There Is No Illumination in Speculation: Additional Data in Support of Methylprednisolone Treatment in ARDS
30. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure
31. Novel Polymorphisms in the Myosin Light Chain Kinase Gene Confer Risk for Acute Lung Injury
32. METHYLPREDNISOLONE INFUSION IN PATIENTS WITH EARLY ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) SIGNIFICANTLY IMPROVES LUNG FUNCTION: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (RCT)
33. Miscellaneous III
34. Noninvasive Positive-Pressure Ventilation vs Conventional Oxygen Supplementation in Hypoxemic Patients Undergoing Diagnostic Bronchoscopy*
35. Noninvasive Ventilation for Treatment of Acute Respiratory Failure in Patients Undergoing Solid Organ Transplantation: A Randomized Trial
36. Noninvasive Positive Pressure Ventilation in Status Asthmaticus*
37. Noninvasive Positive-Pressure Ventilation Via Face Mask During Bronchoscopy With BAL in High-Risk Hypoxemic Patients*
38. Fibroproliferative phase of ARDS: clinical findings and effects of corticosteroids
39. Ventilator-associated pneumonia in patients with respiratory failure: a diagnostic approach
40. General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections.
41. Genome-Wide Association Study in African Americans with Acute Respiratory Distress Syndrome Identifies the Selectin P Ligand Gene as a Risk Factor
42. Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I)
43. Critical Illness-Related Corticosteroid Insufficiency (CIRCI): A Narrative Review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)
44. Temporal Changes in Microrna Expression in Blood Leukocytes from Patients with the Acute Respiratory Distress Syndrome
45. Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness
46. Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us
47. Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS
48. 80. Meduri GU. Why research with improved outcome was blocked by institutions created to protect research and public? Who enforces regulatory compliance to protect rights of patients, accused, and interests of society?
49. Exaggerated plasma Interleukin 6, Interleukin 10, and Subsequent Development of Health Care–Associated Infections in Patients With Sepsis
50. 35
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.